PSTV

PLUS THERAPEUTICS (PSTV)

About PLUS THERAPEUTICS (PSTV)

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.

Details

Daily high

$1.11

Daily low

$0.97

Price at open

$1.01

52 Week High

$2.67

52 Week Low

$0.92

Market cap

6.4M

Dividend yield

0.00%

Volume

49,387

Avg. volume

70,426

P/E ratio

-.49

PLUS THERAPEUTICS News